Volumetric breast density evaluation by ultrasound tomography and magnetic resonance imaging: a preliminary comparative study

Since a 1976 study by Wolfe, high breast density has gained recognition as a factor strongly correlating with an increased incidence of breast cancer. These observations have led to mammographic density being designated a "risk factor" for breast cancer. Clinically, the exclusive reliance on mammography for breast density measurement has forestalled the inclusion of breast density into statistical risk models. This exclusion has in large part been due to the ionizing radiation associated with the method. Additionally, the use of mammography as valid tool for measuring a three dimensional characteristic (breast density) has been criticized for its prima facie incongruity. These shortfalls have prompted MRI studies of breast density as an alternative three-dimensional method of assessing breast density. Although, MRI is safe and can be used to measure volumetric density, its cost has prohibited its use in screening. Here, we report that sound speed measurements using a prototype ultrasound tomography device have potential for use as surrogates for breast density measurement. Accordingly, we report a strong positive linear correlation between volume-averaged sound speed of the breast and percent glandular tissue volume as assessed by MR.

[1]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[2]  N. Boyd,et al.  Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. , 2009, The Lancet. Oncology.

[3]  J. Brisson,et al.  Tamoxifen and mammographic breast densities. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  Anne M Kavanagh,et al.  Using Mammographic Density to Improve Breast Cancer Screening Outcomes , 2008, Cancer Epidemiology Biomarkers & Prevention.

[5]  A. Paterson,et al.  Mammographic breast density as an intermediate phenotype for breast cancer. , 2005, The Lancet. Oncology.

[6]  C. Klifa,et al.  Quantification of breast tissue index from MR data using fuzzy clustering , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[7]  J. Wolfe Risk for breast cancer development determined by mammographic parenchymal pattern , 1976, Cancer.

[8]  M. Yaffe Mammographic density. Measurement of mammographic density , 2008, Breast Cancer Research.

[9]  N. Duric,et al.  Volumetric breast density evaluation from ultrasound tomography images. , 2008, Medical physics.

[10]  Catherine Klifa,et al.  Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort. , 2010, Magnetic resonance imaging.

[11]  Opper,et al.  HERITABILITY OF MAMMOGRAPHIC DENSITY, A RISK FACTOR FOR BREAST CANCER , 2002 .

[12]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[13]  Min-Ying Su,et al.  Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. , 2008, Medical physics.

[14]  Daniel B Kopans,et al.  Basic physics and doubts about relationship between mammographically determined tissue density and breast cancer risk. , 2008, Radiology.

[15]  C. Flowers,et al.  Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population , 2009, BMC health services research.

[16]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.